Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous infusion of Esmolol in patients undergoing CABG surgery
IRCT20200822048478N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of esmolol in coronary arteriosclerosis, sponsored by Kashan University of Medical Sciences. Started Jul 2015; status: completed.
02
Drugs
esmolol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20200822048478N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200822048478N2.